MapMyGenome, India's leading genomics company, has launched MedicaMap — an affordable pharmacogenomics solution that analyzes how an individual's genetic makeup affects their response to over 165 medications across multiple therapeutic areas. MedicaMap makes precision medicine accessible to a broader population, enabling doctors and patients to make more informed medication decisions based on genetic insights.
What Is MedicaMap?
MedicaMap is a comprehensive pharmacogenomic test that analyzes genetic variants in drug-metabolizing enzymes, drug transporters, and drug targets. The test covers medications across cardiology, psychiatry, neurology, oncology, pain management, gastroenterology, and other therapeutic areas — providing actionable insights for over 165 drugs.
Why Pharmacogenomics Matters
Genetic variants in drug-metabolizing enzymes — particularly the cytochrome P450 (CYP) family — can cause 10-fold or greater differences in drug levels between individuals taking the same dose. Poor metabolizers accumulate drugs to toxic levels; ultrarapid metabolizers clear drugs too quickly for therapeutic effect. These differences explain why the same medication at the same dose works brilliantly for one patient and causes serious side effects in another.
"MedicaMap is about making the right medication choice from the start," said Anu Acharya, CEO of MapMyGenome. "Instead of the trial-and-error approach that characterizes much of current prescribing, pharmacogenomic testing allows doctors to select medications and doses that are most likely to be safe and effective for each individual patient."
Key Features of MedicaMap
- Coverage of 165+ drugs across multiple therapeutic areas
- Analysis of key pharmacogenomic genes including CYP2D6, CYP2C19, CYP2C9, CYP3A4/5, SLCO1B1, DPYD, TPMT, and HLA variants
- Clinically actionable report with drug-specific recommendations
- Simple saliva collection from home
- NABL-certified laboratory analysis
- Expert genetic counselor consultation available
Affordability and Access
MedicaMap is priced to be accessible to a broader population than previous pharmacogenomic testing options in India. "We believe that pharmacogenomic testing should not be a luxury available only to the wealthy," said Anu Acharya. "MedicaMap is our commitment to making precision medicine accessible to all Indians."
Find the Right Medicine for Your Genes
MedicaMap by MapmyGenome analyzes your pharmacogenomic profile across 165+ drugs — helping you and your doctor choose medications and doses that are most likely to work safely and effectively for your unique biology.
